Marker Therapeutics MRKR
NASDAQ MRKR
$1.07 -0.06 (-5.31%)
At close: Oct 22, 2026 · 4:00 PM EDT

Marker Therapeutics (MRKR) Interest Coverage Ratio (2010 - 2013)

Updated

Marker Therapeutics' Interest Coverage Ratio was -563.75 in FY2015.

Analysis

Marker Therapeutics (MRKR) Interest Coverage Ratio (2010 - 2013) Analysis & Trends

  • The FY2015 figure marks the highest annual Interest Coverage Ratio since FY2011.
  • Per Business Quant data, Interest Coverage Ratio in earlier years was -4.88 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 28.50
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 10.28
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 7.27
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 5.22
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -42.08
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Marker Therapeutics 20.86 Mn -39.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 -3.33
Jun 30, 2012 -31.31
Mar 31, 2012 -6.95
Dec 31, 2011 -5.05
Sep 30, 2011 -8.72
Jun 30, 2011 -7.15
Mar 31, 2011 -3.08
Dec 31, 2010 -2.97
Sep 30, 2010 -2.69
Jun 30, 2010 -7.54
API Access

Marker Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=MRKR&period=max&api_key=YOUR_API_KEY